par Lynch, John M;Tate, Sarah K;Kinirons, Peter;Weale, Michael E;Cavalleri, Gianpiero L;Depondt, Chantal ;Murphy, Kevin;O'Rourke, Deirdre;Doherty, Colin P;Shianna, Kevin V;Wood, Nicholas W;Sander, Josemir W;Delanty, Norman;Goldstein, David B;Sisodiya, Sanjay M
Référence Epilepsy research, 83, 1, page (44-51)
Publication Publié, 2009-01
Référence Epilepsy research, 83, 1, page (44-51)
Publication Publié, 2009-01
Article révisé par les pairs
Titre: |
|
Auteur: | Lynch, John M; Tate, Sarah K; Kinirons, Peter; Weale, Michael E; Cavalleri, Gianpiero L; Depondt, Chantal; Murphy, Kevin; O'Rourke, Deirdre; Doherty, Colin P; Shianna, Kevin V; Wood, Nicholas W; Sander, Josemir W; Delanty, Norman; Goldstein, David B; Sisodiya, Sanjay M |
Informations sur la publication: | Epilepsy research, 83, 1, page (44-51) |
Statut de publication: | Publié, 2009-01 |
Sujet CREF: | Neurologie |
Mots-clés: | Antiepileptic drugs |
Association studies in genetics | |
Levetiracetam | |
Pharmacogenetics | |
Synaptic vesicle 2A | |
MeSH keywords: | Adult |
Anticonvulsants -- therapeutic use | |
Cohort Studies | |
Epilepsy -- drug therapy -- genetics | |
Epilepsy, Temporal Lobe -- drug therapy -- genetics | |
Female | |
Genetic Predisposition to Disease | |
Genetic Variation | |
Genotype | |
Great Britain | |
Hippocampus -- pathology | |
Humans | |
Ireland | |
Male | |
Membrane Glycoproteins -- genetics | |
Nerve Tissue Proteins -- genetics | |
Piracetam -- analogs & derivatives -- therapeutic use | |
Polymorphism, Genetic -- genetics | |
Synaptic Vesicles -- genetics | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0920-1211 |
info:doi/10.1016/j.eplepsyres.2008.09.003 | |
info:pii/S0920-1211(08)00259-3 | |
info:scp/57849143713 | |
info:pmid/18977120 |